Trial Profile
The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received bevacizumab treatment before the surgery.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2014
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Neovascular glaucoma
- Focus Therapeutic Use
- 01 Jul 2014 New trial record